SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17229770
Source:
http://linkedlifedata.com/resource/pubmed/id/17229770
Search
Subject
(
38
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001792
,
umls-concept:C0087111
,
umls-concept:C0205195
,
umls-concept:C1140680
,
umls-concept:C1442989
,
umls-concept:C1516213
pubmed:issue
2
pubmed:dateCreated
2007-2-7
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17229770-17082510
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0923-7534
pubmed:author
pubmed-author:FerreroAA
,
pubmed-author:ZolaPP
pubmed:issnType
Print
pubmed:volume
18
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
213-4
pubmed:meshHeading
pubmed-meshheading:17229770-Aged
,
pubmed-meshheading:17229770-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:17229770-Carboplatin
,
pubmed-meshheading:17229770-Female
,
pubmed-meshheading:17229770-Geriatric Assessment
,
pubmed-meshheading:17229770-Humans
,
pubmed-meshheading:17229770-Ovarian Neoplasms
,
pubmed-meshheading:17229770-Paclitaxel
,
pubmed-meshheading:17229770-Survival Rate
pubmed:year
2007
pubmed:articleTitle
Is carboplatin-paclitaxel combination the standard treatment of elderly ovarian cancer patients?
pubmed:publicationType
Editorial
,
Comment